Autor: Benjamin Petsch

Dr. Dong Yu currently is Senior Vice President of Research at Dynavax Technologies.  Prior to joining Dynavax, Dr. Yu was the Head of Preclinical R&D US at GSK Vaccines. He received the Ph D from University of Connecticut Health Center. He was a faculty member at Washington University in Saint Louis and the Head of Microbial Molecular Biology at Novartis Vaccines prior to joining GSK Vaccines in 2015.  Dr. Yu authored over 40 publications in various journals and books. His publications reflect his research interests in virology, infectious diseases, and vaccines. Dr. Benjamin Petsch, Senior Director Prophylactic Vaccine Research at Cure Vac AG, Benjamin Petsch joined Cure Vac in 2010 as a scientist in the vaccines department developing m RNA based vaccines against infectious diseases and is heading the department since 2013. He received his university degree from Ludwig-Maximilians-University of Munich and performed his doctoral thesis at the Friedrich-Loeffler-Institut, Tübingen, where he continued as a postdoc and research group leader working on m RNA vaccination against Influenza and on intervention of Influenza replication using small molecules. Dr. Petsch has a 10+ years scientific experience on m RNA based prophylactic vaccines.